Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lightsense Technology has commercialized the DrugDetect-F1, a handheld spectroscopy device for law enforcement field detection of fentanyl and methamphetamine through plastic bags without direct contact with substances[1][2]. The company is developing next-generation multispectral instruments integrating artificial intelligence for expanded drug detection capabilities and bacterial pathogen identification[1][2].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lightsense Technology.